LUXEMBOURG (AFP) — Fränk Schleck, who tested positive for the banned diuretic Xipamide during this year’s Tour de France, will find out what sanction will be imposed next month, AFP learned on Thursday from his entourage.
The elder of the Schleck brothers attended a third and final disciplinary hearing on Wednesday evening at Luxembourg’s anti-doping agency, which was overseen by a representative of the UCI.
“I was able to explain myself once again. I have never made a mistake. The case continues but it’s not finished,” Schleck said as he left the hearing.
According to those involved in the case, the rider’s lawyers claimed the charge against him was “ill-defined” and that the levels of Xipamide — which can be used for weight loss or as a masking agent for other banned substances — in his urine were “infinitesimal.”
Schleck tested positive after the 13th stage of the Tour, on July 14, and quit the race on the second rest day in Pau.
Testing of his B sample also came back positive. Schleck claimed that the sample was either contaminated or the presence of the diuretic was accidental.
According to his lawyers, any sanction taken by January 30 will be backdated to October.